7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $3.9B | -$724000 | 0.0% | 0.4% | $113M | $323M | $576M |
| 2024 | $2.7B | -$128M | 0.0% | -3.8% | -$7M | $321M | $433M |
| 2023 | $1.8B | -$148M | 0.0% | -7.0% | -$95M | $162M | $203M |
| 2022 | $1.4B | -$150M | 0.0% | -9.0% | -$69M | $161M | $410M |
| 2021 | $1.2B | -$195M | 0.0% | -15.2% | — | $151M | $467M |
| 2020 | $959M | -$23M | 0.0% | -0.5% | — | $144M | $207M |
| 2019 | $757M | -$45M | 0.0% | -3.9% | — | — | $86M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.2B | $11M | 0.0% | 1.3% | $121M | $324M | $706M |
| Dec '25 | $1.0B | -$11M | 0.0% | -1.0% | -$55M | $323M | $576M |
| Sep '25 | $994M | $4M | 0.0% | 0.8% | $139M | $323M | $618M |
| Jun '25 | $1.0B | $16M | 0.0% | 2.2% | $21M | $322M | $470M |
| Mar '25 | $927M | -$9M | 0.0% | -0.6% | $8M | $322M | $446M |
| Dec '24 | $701M | -$31M | 0.0% | -3.2% | -$18M | $321M | $433M |
| Sep '24 | $692M | -$26M | 0.0% | -2.8% | $17M | $212M | $340M |
| Jun '24 | $681M | -$24M | 0.0% | -2.7% | $12M | $212M | $339M |
| Mar '24 | $629M | -$47M | 0.0% | -6.5% | -$17M | $162M | $239M |
| Dec '23 | $465M | -$47M | 0.0% | -9.0% | -$198M | $162M | $203M |
| Sep '23 | $457M | -$35M | 0.0% | -6.5% | -$4M | $162M | $392M |
| Jun '23 | $462M | -$28M | 0.0% | -5.1% | $29M | $161M | $395M |
| Mar '23 | $439M | -$37M | 0.0% | -7.4% | $78M | $161M | $384M |
| Dec '22 | $362M | -$57M | 0.0% | -14.4% | — | $161M | $410M |
| Sep '22 | $360M | -$40M | 0.0% | -9.3% | — | $161M | $567M |
| Jun '22 | $366M | -$12M | 0.0% | -1.8% | — | $154M | $453M |
| Mar '22 | $346M | -$41M | 0.0% | -10.6% | — | $152M | $449M |
| Dec '21 | $298M | -$48M | 0.0% | -14.6% | — | $151M | $467M |
| Sep '21 | $293M | -$46M | 0.0% | -14.1% | — | $149M | $500M |
| Jun '21 | $309M | -$45M | 0.0% | -13.1% | — | $147M | $495M |
How the market has priced ALHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Alignment Healthcare, Inc.'s revenue has grown 32.7% per year. These are computed facts, not advice.
As of FY2025, Alignment Healthcare, Inc. reported $323M of total debt against $576M of cash; operating income covered interest expense 0.9×.
In FY2025, gross margin was —, operating margin 0.4%, and net margin -0.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.